PEGylation, the covalent modification of proteins with polyethylene glycol, is an abundantly used technique to improve the pharmacokinetics of therapeutic proteins. The drawback with this methodology is that the covalently attached PEG can impede the biological activity (e.g. reduced receptor-binding capacity). Protein therapeutics with "disposable" PEG modifiers have potential advantages over the current technology. Here, we show that a protein-polymer "Medusa complex" is formed by the combination of a hexavalent lectin with a glycopolymer. Using NMR spectroscopy, small angle X-ray scattering (SAXS), size exclusion chromatography and native gel electrophoresis it was demonstrated that the fucose-binding lectin RSL and a fucose-capped polyethylene glycol (Fuc-PEG) form a multimeric assembly. All of the experimental methods provided evidence of noncovalent PEGylation with a concomitant increase in molecular mass and hydrodynamic radius. The affinity of the protein-polymer complex was determined by ITC and competition experiments to be in the µM range, suggesting that such systems have potential biomedical applications.
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Introduction
The modification of proteins with synthetic polymers is a powerful route to novel functionalized macromolecules with applications in biotechnology and medicine. [1] [2] [3] [4] [5] [6] [7] PEGylation, the covalent attachment of polyethylene glycol, is a versatile means to increase a protein's size, stability and solubility. 2, [8] [9] [10] [11] The increased radius of protein-PEG conjugates leads to a reduction in renal filtration, which together with decreased immunogenicity can result in longer circulation half lives compared to the native protein. 9 ,10 Such improvements in pharmacokinetics are crucial for the development of cost-effective and patient-friendly protein therapeutics. However, PEGylation can also interfere with the processes of molecular recognition and lead to reduced biological activity. Steric hindrance of the binding site by PEG can impede complex formation with the target receptor. 9, 10 This effect may be eliminated in poly(zwitterion)-based conjugates. 4 Furthermore, reversible PEGylation strategies have been developed that take advantage of slowly hydrolysable, 12,13 light-sensitive 14 or thiol-sensitive 15 linkers to release the PEG component.
With the growing demand for tunable protein-polymer macromolecules the focus of attention is shifting towards noncovalent conjugates. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] Examples include polymer conjugation via: co-factor reconstitution, 16 the biotin-streptavidin complex, 18 supramolecular complexation with cucurbituril, 19 charge-charge 20 and metal affinity 21, 24 interactions, as well as lectin-mediated complexation. 25, 27, 28 The advantage of noncovalent systems is that temporal control of conjugate assembly and disassembly can be asserted by the presence of competitor molecules. 19 In the context of protein therapeutics it is envisaged that the biologically-active ligand-receptor complex may act as a competitor to displace the lower affinity polymer interaction. Thus, the potential interference caused by covalently attached PEG chains will be minimised. Noncovalent
PEGylation involves several challenges, the foremost being the control of the protein-polymer affinity which must be sufficiently high to enable the positive effects of PEGylation (i.e.
increased circulation half life) and yet low enough to permit transient unbinding and competition by the host receptor (K d ~nM-µM). Coupled to this challenge is the need for simple linker chemistries which are biocompatible, synthetically attractive and inexpensive.
At this point we note that the study of noncovalent protein-PEG assemblies is not new.
Early applications were focused on protein purification by phase separation in mixtures of dextran and dye-conjugated PEG. [29] [30] [31] Figure 4 in reference 30 is startling in its originality and relevance to current developments. Biomacromolecules   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 4
Here, we have combined a fucose-binding lectin with a fucose-capped polyethylene glycol (Fuc-PEG) to produce a noncovalent protein-polymer "Medusa complex" (Figure 1 ). polymer. This strategy of noncovalent PEGylation may benefit the development of lectinmediated drug delivery systems.
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Materials.
Methyl-α-L-fucoside (Me-fuc) and L-galactose (L-gal) were purchased from Carbosynth and Sigma, respectively. L-fucose-capped polyethylene glycol (Fuc-PEG) was synthesized via a copper catalyzed azide-alkyne cycloaddition 40 (Supporting Information, Scheme S1). Alkyne terminated PEG (Alk-PEG) was prepared according to an adapted literature procedure, 41 by using PEG monomethyl ether (~2 kDa, Sigma 202509) and propargyl bromide.
The 1 H NMR spectrum of Alk-PEG included peaks at 2.42 and 4.18 ppm, assigned to the alkyne proton and the adjacent CH 2 protons, respectively ( Figure S1 ). 2-azidoethyl α-L-fucose was synthesized as described. 42 For the click reaction, stoichiometric amounts of Alk-PEG and 2-azidoethyl α-L-fucose were combined in t-butanol/water (5:1) in the presence of copper sulfate (0.1 eq.) and sodium ascorbate (0.2 eq.) at 50 °C for 24 h (Figures S1 and S2). The product was purified by flash chromatography and formation of the triazole was confirmed by 1 H NMR ( Figure S2 ) and ATR-FTIR spectroscopy ( Figure S3 ).
Protein samples. RSL was produced in E. coli BL21, transformed with the plasmid pET25rsl, and purified by mannose-affinity chromatography. 32 The 15 N-labeled protein was prepared as described recently.
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Size exclusion chromatography. SEC was carried out at 21° C on an Äkta FPLC equipped with an XK 16/70 column (1.6 cm diameter, 65 cm bed-height) packed with Superdex 75 (GE Healthcare). Filtered, degassed buffer (20 mM KPi, 50 mM NaCl, pH 6.0) was used at a constant flow rate of 1.5 mL/min. The samples (800 µL) contained RSL (0.25 mM) with 12 eq. of Fuc-PEG or Me-fuc. Sample elution was monitored at 280 nm.
Electrophoretic characterization of noncovalent PEGylation. Native electrophoresis was performed using 5% polyacrylamide or 2% agarose gels (6.0 cm x 7.0 cm) in horizontal mode. Isothermal titration calorimetry. Experiments were performed at 25° C using a Nano ITC (TA Instruments) and conditions similar to those previously published. 32 Samples of protein (24 µM) and ligands (1-2 mM) were prepared in identical buffer (0.1 M Tris-HCl, pH 7.5). Ligand solutions were added in 30 injections of 3 µl at intervals of 3 min while stirring at 300 rpm. A control experiment was performed by injecting Fuc-PEG into buffer, which yielded negligible heats of dilution. The data analysis was performed in NanoAnalyze.
SAXS characterization.
Small-angle X-ray scattering experiments were performed at the ESRF BioSAXS beamline BM29 equipped with a Pilatus 1M detector (Dectris). 48, 49 RSL bound to Mefuc or to Fuc-PEG was characterized at four different protein concentrations (10, 5, 2 and 1 mg/ml) using the automated sample changer. 50 Data were collected also on a sample of the conjugate that was pre-treated via an online SEC at BM29. 51 All of the samples were prepared in the same buffer, identical to that used for the NMR experiments. 55 (automated sample changer) or 100 (SEC) µl volumes were exposed to X-rays for 10 individual frames, each 1 second in duration. Individual frames were processed with the automatic processing pipeline 52 , to yield individual radially-averaged curves of normalized intensity versus scattering angle s = 4πsinθ/λ.
Additional data reduction in EDNA utilized the automatic data processing tools of the EMBLHamburg ATSAS package 53, 54 to combine timeframes (excluding any data points affected by radiation damage), yielding the average scattering curve for each exposure series. Matched buffer measurements taken before and after every sample were averaged and used for background subtraction. Merging of separate concentrations and further analysis were performed manually using the ATSAS package. The forward scattering I(0) and radius of gyration R g were calculated from the Guinier approximation. 56 The hydrated particle volume was computed using the Porod invariant 57 and the maximum particle size D max was determined from the pair distribution function computed by GNOM 58 in PRIMUS. 59 An estimate of the molecular mass (MM) of each construct was made from the I(0), with the partial specific volumes of RSL and PEG taken as 0.74 and 0.83 cm 3 /g, respectively. 60 Ab initio models were calculated using DAMMIF 61 and then averaged, aligned and compared in DAMAVER. 62 CRYSOL 63 was used to calculate the scattering of RSL based on the crystal structure coordinates 32 (PDB 2BT9). In CORAL, 6 x 22 dummy residues with random coil conformations (P 1 symmetry) were added to account for the six Fuc-PEG chains.
The assumption of 22 residues per Fuc-PEG was based on the molecular weight (~2.3 kDa) and
Svergun's demonstration that the electron density of PEG (~0.4 e/Å 3 ) is comparable to that of protein. 60 The averaged and filtered model was used to visualize the protein-polymer assembly and SUPCOMB 64 was used to optimally orient the RSL crystal structure (with minimal spatial discrepancy) into the final model. Fits of the models to the experimental data were prepared in SAXSVIEW (http://saxsview.sourceforge.net). 
Results and Discussion
Biochemical characterization of RSL bound to Fuc-PEG. The formation of a noncovalent conjugate between RSL and Fuc-PEG was expected to yield a particle of ~50 % increased mass (compared to RSL, ~29 kDa). Assuming that all six sugar-binding sites are occupied by Fuc-PEG (~2.3 kDa) the conjugate will have a mass of ~43 kDa.
An initial characterization of the conjugate was performed by using size exclusion chromatography. RSL in the presence of 12 equivalents of Me-fuc (K d ~0.6 µM 32 ) eluted at ~75 mL ( Figure S4 ). This elution volume was higher than expected (the ~31 kDa DNase eluted at ~65 mL) and suggests that RSL interacted weakly with the Superdex resin. In the presence of Fuc-PEG, elution was observed at ~55 mL, which corresponds to proteins of ~66 kDa (as indicated by a BSA standard). This higher-than-expected mass is characteristic of PEGylated proteins as the random coil nature of PEG occupies a larger volume than a corresponding mass of folded protein. 11, 65, 66 The peak at ~43 mL, corresponding to the void volume, suggested the presence of high molecular weight aggregates. This observation suggests that noncovalent PEGylation produced larger particles that were more effectively retarded by the gel.
NMR characterization.
15 N-labelled RSL was titrated with µL aliquots of Fuc-PEG (10 mM stock) and monitored by 1 H-15 N TROSY-HSQC spectroscopy. The TROSY was necessary to improve spectral quality, consistent with the increased molecular mass and longer tumbling time of the conjugate ( Figure S5 shows a comparison of the HSQC and TROSY-HSQC spectra of RSL bound to Fuc-PEG). The protein-polymer interaction was in slow-exchange on the NMR timescale consistent with an equilibrium dissociation constant in the micromolar range. 35, 47 Considering the overall similarity of the spectra of RSL bound to Me-fuc and RSL bound to Fuc-PEG ( Figure S6 ) it was evident that the highly-stable RSL structure 32 was unaltered by interaction with the polymer. PEG were >2 times larger than in the Me-fuc form ( Figure 3C ). Lys34 and Asn79 are structurally equivalent residues located in loops that flank the inter-and intra-monomeric sugar binding sites, respectively. 32, 35 The backbone N atom of these residues is within 7.8 Å of the methyl substituent of Me-fuc in the RSL crystal structure (PDB 2BT9). 32 The large ∆δ observed for these resonances (relative to the Me-fuc data) is evidence that the bulky Fuc-PEG polymer interacts at these sites. Note that the adjacent residues (33, 35 and 78, 80) are glycines and no amide resonances were observed in the sugar-free 35 or in the polymer-bound form.
The ~50 % increase in molecular mass of the RSL conjugate was expected to result in Therefore, it can be concluded that the observed line width changes were due to noncovalent PEGylation (rather than aggregation).
To assess whether the PEG alone contributed to the observed chemical shift perturbations control experiments were performed using PEG 2000 (the starting material for the Fuc-PEG synthesis). There were no appreciable effects on the NMR spectrum of RSL ( Figure S7 ) Small angle X-ray scattering. RSL samples, at a maximum concentration of ~10 mg/mL, bound to Me-fuc or Fuc-PEG were characterised by SAXS. Data collection was performed using both the automated sample changer and the online SEC at BM29. The online SEC was used to remove high molecular weight aggregates (>150 kDa, Figure S4 ) immediately prior to data collection.
The molecular mass (MM), the radius of gyration (R g ), the maximum particle size (D max ), and the volume (V) of RSL bound to Me-fuc were estimated at 27 ±3 kDa, 1.8 ±0.1 nm, 4.8 ±0.2 nm, and 42 nm 3 , respectively. These parameters coincide, within error, with those computed from the RSL crystal structure (PDB 2BT9). The predicted scattering curve (CRYSOL) from the crystal structure fits neatly to the experimental data (χ = 1.97, Figure 5) . Ab initio models calculated in DAMMIF 61 (with P 1 or P 6 symmetry, Figure 5 ) matched the crystal structure ( Figure 6 ). All of these data confirmed that RSL is a trimer in solution. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 11 conjugate. The difference in molecular weight between RSL bound to Me-fuc and RSL bound to Fuc-PEG was ~15 kDa in agreement with the expected mass difference of 13.8 kDa. Ab initio models generated in DAMMIF 61 had six, three or one elongated protrusions that fit the experimental data with χ = 3.5, 2.8 or 2.4 for P 6 , P 3 and P 1 symmetry, respectively. The fit and corresponding envelope for P 6 are shown in Figures 5 and 6B . As the resolution of the ab initio modelling was insufficient to determine the locations of the PEG chains, constrained rigid body modelling was performed in CORAL. 54 Chains of 22 dummy residues, based on Svergun's approximation, 60 were used to model the Fuc-PEG. The Fuc-PEG appendages were constrained to the known fucose-binding sites (at residues Trp31 and Trp76 of the inter-and intramonomeric binding sites). 32, 35 The resulting model gave good fits to the scattering data (χ = 2.4) and overlaid neatly with the P 6 ab initio envelope ( Figure 6B ). Irrespective of the modelling strategy and in agreement with earlier studies 11,60,69 the Fuc-PEG chains were observed to extend away from the protein core, rather than interact with the protein surface. Therefore, the SAXS data were consistent with the proposed "Medusa complex".
RSL and Fuc-PEG are an interesting model system in the context of the "grafting distance" (D G ) and the Flory dimension (R F ) of the polymer. 11, 60 The fucose-binding sites in RSL have a hexagonal arrangement with an edge length of ~2 nm (distance between the methyl substituents in Me-fuc crystal structure, PDB 2bt9). PEG 2000 has a R F of ~3.5 nm, which is ~1.7-fold the grafting distance (nearest neighbours). As D G < R F the tendency is for the PEG to adopt an extended "brush" conformation and thereby reduce steric interactions between the polymer chains. This model is well-represented by the SAXS data ( Figure 6B ).
Conclusions
We have demonstrated the possibility of noncovalent PEGylation in a protein-polymer conjugate based on the hexavalent lectin RSL and a fucose-capped PEG. A variety of biophysical techniques were used to characterize complex formation. By using NMR spectroscopy it was confirmed that the glycopolymer interacts with the fucose-binding sites of the protein. The chemical shift perturbation plot was consistent with previously obtained data for the binding of "fucose like" sugars. 35 The increase in NMR line widths and the necessity of the TROSY pulse 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 12 reversible nature of the complex was demonstrated by competition experiments. The Fuc-PEG appendages were displaced by the tighter binding Me-fuc (while the weaker binding L-gal had no effect). Small angle X-ray scattering was used to elucidate the structure of the conjugate. The scattering data were consistent with a protein-polymer "Medusa complex" in which the PEG chains were extended from the protein core. In terms of broader applications, noncovalent
PEGylation could involve proteins with an engineered sugar-binding site and a glyco-PEG with appropriate sugar functionality and PEG size. Alternatively, glyco-PEGs could be used as modifiers in drug delivery systems where lectin-bioadhesives control recognition and targeting.
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